Fund Holdings — Pennant Investors, LP

Total Portfolio Value:
$361.74M
Total Bought:
$37.56M
Total Sold:
$24.76M
Net Transaction:
+$12.80M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Amazon.com, Inc.(AMZN)348,000296,000-52,000$52.88M$53.39M14.76%+$517.4K
TransDigm Group Incorporated(TDG)42,00042,0000$42.49M$51.73M14.30%+$9.24M
Microsoft Corporation(MSFT)129,000112,000-17,000$48.51M$47.12M13.03%-$1.39M
Micron Technology, Inc.(MU)306,000306,0000$26.11M$36.07M9.97%+$9.96M
Antero Resources Corporation(AR)913,0001,133,000+220,000$20.71M$32.86M9.08%+$12.15M
EchoStar CorporationCL A(ECHO)2,153,2092,153,2090$35.68M$30.68M8.48%-$5.00M
Alphabet Inc.CL A(GOOG)375,000199,000-176,000$52.38M$30.04M8.30%-$22.35M
Enovis Corporation(ENOV)0400,000+400,000$0$24.98M6.91%+$24.98M
The Odp Corp400,000400,0000$22.52M$21.22M5.87%-$1.30M
Perimeter Solutions, Inc.(PRM)2,300,0002,300,0000$10.58M$17.07M4.72%+$6.49M
Fibrogen Inc768,400768,4000$681.0K$1.81M0.50%+$1.12M
Arcutis Biotherapeutics, Inc.(ARQT)170,900170,9000$552.0K$1.69M0.47%+$1.14M
Altimmune, Inc.(ALT)109,800109,8000$1.24M$1.12M0.31%-$117.5K
Fate Therapeutics, Inc.(FATE)146,100146,1000$546.4K$1.07M0.30%+$526.0K
Nurix Therapeutics, Inc.(NRIX)56,80056,8000$586.2K$835.0K0.23%+$248.8K
MacroGenics, Inc.(MGNX)43,80043,8000$421.4K$644.7K0.18%+$223.4K
Igm Biosciences Inc64,90064,9000$539.3K$626.3K0.17%+$87.0K
Enanta Pharmaceuticals, Inc.(ENTA)35,10035,1000$330.3K$612.8K0.17%+$282.6K
Allogene Therapeutics Inc128,400128,4000$412.2K$573.9K0.16%+$161.8K
89bio Inc44,50044,5000$497.1K$518.0K0.14%+$20.9K
Zentalis Pharmaceuticals, Inc.(ZNTL)32,40032,4000$490.9K$510.6K0.14%+$19.8K
Arcus Biosciences, Inc.(RCUS)23,70023,7000$452.7K$447.5K0.12%-$5.2K
Arcturus Therapeutics Holdings Inc.(ARCT)13,10013,1000$413.0K$442.4K0.12%+$29.3K
Agios Pharmaceuticals, Inc.(AGIO)15,10015,1000$336.3K$441.5K0.12%+$105.2K
Travere Therapeutics IncNOTE 2 500 9 1055,800+55,800$0$430.2K0.12%+$430.2K
Getaround Inc1,348,1531,348,1530$316.8K$413.9K0.11%+$97.1K
Zymeworks Inc.(ZYME)38,70038,7000$402.1K$407.1K0.11%+$5.0K
Coherus Oncology, Inc.(CHRS)168,100168,1000$559.8K$401.8K0.11%-$158.0K
Compass Therapeutics, Inc.(CMPX)199,000199,0000$310.4K$394.0K0.11%+$83.6K
Relay Therapeutics, Inc.(RLAY)42,40042,4000$466.8K$351.9K0.10%-$114.9K
Erasca, Inc.(ERAS)166,200166,2000$354.0K$342.4K0.09%-$11.6K
Sage Therapeutics Inc17,50017,5000$379.2K$327.9K0.09%-$51.3K
Novavax, Inc.(NVAX)60,30060,3000$289.4K$288.2K0.08%-$1.2K
Agenus Inc.(AGEN)469,600469,6000$388.8K$272.4K0.08%-$116.4K
uniQure N.V.SHS(QURE)48,50048,5000$328.3K$252.2K0.07%-$76.1K
Replimune Group, Inc.(REPL)30,50030,5000$257.1K$249.2K0.07%-$7.9K
BioXcel Therapeutics, Inc.(BTAIQ)83,90083,9000$247.5K$236.6K0.07%-$10.9K
Allakos Inc186,100186,1000$508.1K$234.5K0.06%-$273.6K
Seres Therapeutics, Inc.(MCRB)292,300292,3000$409.2K$226.3K0.06%-$183.0K
Allovir Inc215,700215,7000$146.6K$162.8K0.05%+$16.2K
Airspan Networks Holdings In1,047,4731,047,4730$94.3K$118.4K0.03%+$24.1K
Bluebird Bio Inc87,40087,4000$120.6K$111.9K0.03%-$8.7K
Grab Holdings LimitedW EXP 99 99 999
*W EXP 99/99/999
80,00080,0000$18.0K$16.2K0.00%-$1.8K
Travere Therapeutics, Inc.(TVTX)55,8000-55,800$501.6K$0—-$501.6K
Page 1 of 1
Pennant Investors, LP — 13F Holdings — Q1 2024 | TickerTrail